|
CRF Appoints Andrew F. Kraus as Chief Operating Officer
|
|
James K. Min, MD Joins the Cardiovascular Research Foundation as Director of Non-Invasive Imaging
|
|
The Pulse of CRF Winter 2013, TCT Issue
|
|
Cutting-Edge Clinical Research Presented at TCT 2013
|
|
CRF Selects Jack Lewin, MD, to Serve as President and CEO
|
|
In Memoriam: Andreas Gruentzig, MD, Receives TCT Career Achievement Award
|
|
TCT Goes Tablet
|
|
New Study Demonstrates Potential Benefits of Shorter-Term Dual Antiplatelet Therapy in Patients Treated with a Second Generation Drug-Eluting Stent
|
|
New Study Finds Patients who are Event-Free Following PCI at One Year May Not Need Prolonged Dual Antiplatelet Therapy
|
|
Comparison of Two Third-Generation Drug-Eluting Stents Establishes Comparable Safety and Efficacy; Demonstrates Non-Inferiority of Newest Zotarolimus-Eluting Stent
|
